PROM1 and endometrium neoplasm: Interestingly, we analyzed the methylation status of a primary tumor sample and compared it to its corresponding serial transplants and found the level of CD133 promoter methylation relative to that detected in the primary human endometrial tumor appeared to be reduced over the course of serial transplantation.